Monthly Archives September 2019

Click here to access the analysis for Fluoxetine. Note that this offer is in place prior to the beginning of the 5 month Dual listing transition period which commences 1 November 2019. Fluoxetine-Arrow will remain fully funded at existing schedule price until 31 March 2019. We encourage you to continue to support the incumbent products until stocks are depleted or…

Click here to access the analysis for Sertraline Tablets. Note that this is the beginning of the 5 month Dual listing transition period and Sertraline-Arrow will remain fully funded at existing schedule price until 1 March 2019. We encourage you to continue to support the incumbent products until stocks are depleted or Sole Supply commences, whichever comes first. ProPharma /…

Click here to read the GSK notification relating to the above mentioned product. You must immediately complete and fax the acknowledgement form provided regardless of whether you have stock or not. This is a requirement under your current ICPSA . NOTE: ProPharma /PWR will be processing credit returns and all credit returns must be accompanied by a copy of the…

Click here to read the original notifications for Cetomacrogol with glycerol, Furosemide Tab 40 mg , Metoclopramide Inj, Paroxetine Tab, Povidone Iodine Antiseptic Soln 10% 15ml & 500 ml, Ropinirole Tab and Sertraline Tab. Most of these products will have DUAL listings in the Pharmaceutical Schedule & where applicable HML from 1 October 2019 until 28 February 2020. The exception…

1 temporary shortage and 2 notifications of supply interruption. Click here to read the supplier notification of a temporary shortage of Heparin Inj 25,000 iu per ml, 0.2 ml Pharmacodes 333085 and 2567032. Click here to read the supplier notification of a Supply Interruption of Sulfamethoxazole 80mg/ml and Trimethoprim 16mg/ml DBL in a 5 ml ampoule 5 pack Pharmacode 764965.…

Novartis have advise that supply has resumed and stock is expected into our warehouses either 19th or 20th September 2019 The supply issue was originally disrupted August 2019. Apologies for any inconvenience caused, however it was outside our control. We thank you in anticipation of your ongoing support.

Click here to read the notification from Apotex relating to the resupply of the above mentioned product. The supply issue was originally disrupted April 2019. Alternative product Clomipramine-Apo Tab 25 mg 50 Pharmacode 2565773 was made available to ensure continuity of supply. Please be advised that we will not release the 100 pack until all of the stock of the…

As advised via PHARMAC Tender Results of 29 March 2019 there is to be a change in the listing and future sole supply of Temozolomide Capsules. Please refer to our original notification of 29 March 2019 for original timings as all but 5 mg will now been listed from 1 October 2019 to ensure ongoing supply. (Only the listing date…

In association with GSK we are republishing this information (first published 29 May 2019) as there remains a lot of uncertainty and confusion in the market, particularly from patients. A classic example was on Stuff Friday 13th September 2019. https://www.stuff.co.nz/national/health/115711290/taranaki-man-fearful-drug-funding-change-will-bring-back-a-life-of-seizures Our industry does not need more of these stories and pharmacy needs to be on the front foot and have…

Please be advised that there is to be a change in the presentation of 3 Nutrison products at varying times from 1 October 2019 to 1 December 2019. Click here to read the notification from Nutricia. The new packaging will transition in from Nutricia on the approximate dates shown in their notification and will then transition through wholesale as existing…

Close